| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.130 | 23.311 | 28.255 | 27.403 | 21.430 | 30.506 | 33.756 | 46.141 | 40.747 |
| Total Income - EUR | - | 1.130 | 23.313 | 28.257 | 27.408 | 21.449 | 30.511 | 33.764 | 46.154 | 40.761 |
| Total Expenses - EUR | - | 671 | 11.253 | 9.038 | 11.247 | 9.636 | 12.303 | 12.179 | 18.703 | 18.384 |
| Gross Profit/Loss - EUR | - | 459 | 12.059 | 19.219 | 16.161 | 11.814 | 18.207 | 21.585 | 27.451 | 22.376 |
| Net Profit/Loss - EUR | - | 449 | 11.826 | 18.372 | 15.889 | 11.600 | 17.939 | 21.254 | 27.059 | 21.337 |
| Employees | - | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ivacson Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 941 | 9.712 | 9.941 | 8.508 | 7.103 | 5.904 | 4.670 | 3.434 |
| Current Assets | - | 1.158 | 30.044 | 36.424 | 50.684 | 8.655 | 27.603 | 37.477 | 64.925 | 68.905 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 596 | 741 | 816 | 1.673 | 837 | 1.572 | 1.365 | 3.077 | 782 |
| Cash | - | 563 | 29.302 | 35.608 | 49.011 | 7.818 | 26.031 | 36.112 | 61.848 | 68.124 |
| Shareholders Funds | - | 494 | 12.311 | 30.457 | 45.756 | 16.175 | 33.755 | 22.028 | 49.020 | 70.083 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 777 | 18.683 | 15.821 | 14.940 | 1.027 | 1.050 | 21.408 | 20.634 | 2.340 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ivacson Med S.r.l.